Despite recent revenue growth, the company's high P/S ratio ...
Despite recent revenue growth, the company's high P/S ratio compared to the industry could disappoint shareholders. Slower revenue growth and an elevated P/S suggest a risk of share price decline. Continuation of medium-term revenue trends could put investments at risk and potential investors may pay an excessive premium.
What Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) 27% Share Price Gain Is Not Telling You
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment